Drugstore chain Rite Aid Corporation (NYSE: RAD) announced fourth-quarter 2023 results, reporting a modest increase in revenues and a narrower net loss.
Fourth-quarter loss, excluding special items, improved to $1.24 per share from a loss of $2.24 per share in the same period of last year. On a reported basis, the net loss attributable to common stockholders was $241.3 million or $4.39 per share, compared to a loss of $389.1 million or $7.18 per share in the prior-year quarter.
Total revenues increased modestly to $6.09 billion in the fourth quarter from $6.07 billion in the corresponding period of 2022. Retail comparable same-store prescriptions moved up 5.2% while comparable same-store prescriptions, excluding COVID impacts, increased 9.7%.
“We are making progress in our turnaround program to drive performance acceleration that we expect will help mitigate fiscal 2024 challenges related to reimbursement, COVID headwinds, and enrollment at Elixir, and to drive meaningful Adjusted EBITDA growth in fiscal 2025 and 2026,” said interim chief executive officer Elizabeth Burr.
Most Popular
AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates
Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings. The company reported worldwide net revenues of $13.3 billion for the
Colgate-Palmolive (CL) Q1 2025 Earnings: Key financials and quarterly highlights
Colgate-Palmolive Company (NYSE: CL) reported its first quarter 2025 earnings results today. Net sales decreased 3.1% year-over-year to $4.9 billion. Organic sales growth was 1.4%. Net income attributable to Colgate-Palmolive Company rose
Meta Platforms (META) set to report Q1 earnings. Here’s what to expect
After integrating artificial intelligence into its products, Meta Platforms, Inc. (NASDAQ: META) is investing heavily in the metaverse project. Yet, the tech giant has maintained healthy cash flows and consistently
